The Healthcare Effects of the Ochsner Hypertension Digital Medicine Program


Cong M, Liu M, Ouyang J, Dunne S, Vicidomina B, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

OBJECTIVES : To evaluate whether the Ochsner Health System’s Hypertension Digital Medicine Program (HDMP) improved enrollee blood pressure (BP), and utilization.

METHODS : Patients with hypertension (HTN) could enroll in Ochsner’s HDMP. Program benefits include blood pressure tele-monitoring in home, pharmacy management and in-depth education. Patients had to be residents of Louisiana and have no history of a heart or kidney transplant. The treatment group included all patients enrolled in the HDMP and were continuously enrolled in Quality Blue Primary Care at least 6 months before and after the HDMP participation date. Propensity scoring was used to match the treatment group to a control population, not being managed by Ochsner PCPs. Patients were further categorized by whether or not their BP was controlled, defined as less than 140/90 mmHg in the baseline period. Difference-in-difference regression models was used to measure the program effects on BP control, healthcare utilization, medication adherence and costs.

RESULTS : After matching, each of the cohorts BP controlled and uncontrolled at baseline had a total of 244 and 167 patient pairs, respectively. Members in the treatment group, regardless of whether or not their BP was controlled at baseline had significantly improved their BP and HTN related medication adherence. Emergency department and specialty visits were also lower for the treatment group who had uncontrolled BP at baseline.

CONCLUSIONS : Ochsner Health System’s HDMP improved enrollee BP, medication adherence, and healthcare utilization.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)




Clinical Outcomes, Health Service Delivery & Process of Care, Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance, Clinical Outcomes Assessment, Disease Management, Patient Engagement


Cardiovascular Disorders

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now